EVP-0962
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EVP-0962, covering 2014-01-13 to 2014-01-13. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics of EVP-0962 and Effects of EVP-0962 on Cerebral Spinal Fluid Amyloid Concentrations in Healthy Subjects and in Subjects With Mild Cognitive Impairment or Early Alzheimer's Disease [Phase 2]